BIOMAT Database Logo BIOMAT Database Logo

Pseudomonas cepacia in 16 non-fatal cases of postoperative bacteremia derived from intrinsic contamination of the anaesthetic fentanyl. Clinical and epidemiological observations in Denmark and Holland. 1979

K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen

From Nov. 15 to Dec. 17, 1977, Pseudomonas cepacia was isolated from the blood of 16 patients in Odense, Denmark, and Nijmegen, Holland, 2--5 days after an operation with general anaesthesia. The fever started 14--70 h after operation and lasted 2--4 days. All patients recovered. 14/15 patients examined 7--51 days later had agglutinating antibody titres of 400-3,200 against the epidemic strain. Ps. cepacia with identical biochemical characters and sensitivity pattern was isolated from unbroken vials containing the anaesthetic fentanyl, which had been given to all 16 patients. Two batches were contaminated, one heavily so (10(4)--10(5) cfu/0.1 ml). Seven other batches examined yielded no growth. The preservative added to the vials was a mixture of methyl- and propyl-p-hydroxybenzoates which not only allowed growth of the Ps. cepacia strain but could also serve as a carbon source as did citric and malonic acids. The concentration of preservative was not reduced in contaminated vials. The vials had not been sterilized after closure; too much reliance had been placed on an aseptic technique and insufficient preservatives.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011310 Preservatives, Pharmaceutical Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants. Pharmaceutic Aids (Preservatives),Pharmaceutic Preservative,Pharmaceutic Preservatives,Pharmaceutical Preservative,Pharmaceutical Preservatives,Preservative, Pharmaceutic,Preservative, Pharmaceutical,Preservatives, Pharmaceutic
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003718 Denmark A country in northern Europe, bordering the Baltic Sea and the North Sea. The capital is Copenhagen. Faeroe Islands,Faroe Islands
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations

Related Publications

K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen
Clinical and laboratory characteristics of Pseudomonas cepacia bacteremia.
January 1983, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen
Investigations of intrinsic Pseudomonas cepacia contamination in commercially manufactured povidone-iodine.
May 1991, Infection control and hospital epidemiology,
K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen
[Staphylococcal bacteremia. IV. Bacteriological, epidemiological and clinical observations in 462 cases from the years 1957 to 1960].
April 1962, Ugeskrift for laeger,
K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen
Outbreak of Pseudomonas cepacia bacteremia in oncology patients.
March 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen
[Pseudomonas aeruginosa bacteremia: clinical and epidemiological patterns and treatment].
December 2002, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen
[Burkholderia cepacia infection in children: a clinical analysis of 16 cases].
February 2018, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen
Recent trends of isolates from cases of bacteremia in Denmark.
January 1974, Scandinavian journal of infectious diseases,
K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen
Some observations on the use or abuse of medicine in Holland-Finland-Denmark.
January 1953, Acta psychiatrica et neurologica Scandinavica,
K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen
Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia.
January 1987, Antimicrobial agents and chemotherapy,
K Siboni, and H Olsen, and E Ravn, and P Søgaard, and A Hjorth, and K N Nielsen, and K Askgaard, and B Secher, and J Borghans, and L Khing-Ting, and H Joosten, and W Frederiksen, and K Jensen, and N Mortensen, and O Sebbesen
Outbreak of Burkholderia cepacia complex bacteremia in a chemotherapy day care unit due to intrinsic contamination of an antiemetic drug.
January 2015, Indian journal of medical microbiology,
Copied contents to your clipboard!